Ilona Bednarek

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 11

Top Venues

International journal of molecular sciences

Archives of gynecology and obstetrics

Biomedicines

Molecular biology reports

Thomas Jefferson University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Thomas Jefferson University Aug 1o 1998

United States

postdoctoral research fellow :: Department of Microbiology and Immunology

Publications

Aleksandra Zoń, Ilona Bednarek
Cisplatin in Ovarian Cancer Treatment-Known Limitations in Therapy Force New Solutions. International journal of molecular sciences 24 (8) (2023)
Aleksandra Zoń, Ilona Bednarek
Cisplatin in Ovarian Cancer Treatment-Known Limitations in Therapy Force New Solutions. International journal of molecular sciences 24 (8) (2023)
Aleksandra Zoń, Ilona Bednarek
Cisplatin in Ovarian Cancer Treatment-Known Limitations in Therapy Force New Solutions. International journal of molecular sciences 24 (8) (2023)
Aleksandra Zoń, Ilona Bednarek
Cisplatin in Ovarian Cancer Treatment-Known Limitations in Therapy Force New Solutions. International journal of molecular sciences 24 (8) (2023)
Paulina Borzdziłowska, Ilona Bednarek
The Effect of α-Mangostin and Cisplatin on Ovarian Cancer Cells and the Microenvironment. Biomedicines 10 (5) (2022)
Paulina Borzdziłowska, Ilona Bednarek
Alpha Mangostin and Cisplatin as Modulators of Exosomal Interaction of Ovarian Cancer Cell with Fibroblasts. International journal of molecular sciences 23 (16) (2022)
Jakub Rech, Daniel Sypniewski, Dorota Żelaszczyk, Natalia Szkaradek, Wojciech Rogóż, Anna M Waszkielewicz, Henryk Marona, Ilona Bednarek
Novel Xanthone Derivatives Impair Growth and Invasiveness of Colon Cancer Cells In Vitro. Biomolecules 11 (10) (2021)
Ewa Nowak, Ilona Bednarek
Aspects of the Epigenetic Regulation of EMT Related to Cancer Metastasis. Cells 10 (12) (2021)
Ewa Nowak, Daniel Sypniewski, Ilona Bednarek
Morin exerts anti-metastatic, anti-proliferative and anti-adhesive effect in ovarian cancer cells: an in vitro studies. Molecular biology reports 47 (3) (2020)
Dominik Bieg, Daniel Sypniewski, Ewa Nowak, Ilona Bednarek
Morin decreases galectin-3 expression and sensitizes ovarian cancer cells to cisplatin. Archives of gynecology and obstetrics 298 (6) (2018)
Dominik Bieg, Daniel Sypniewski, Ewa Nowak, Ilona Bednarek
MiR-424-3p suppresses galectin-3 expression and sensitizes ovarian cancer cells to cisplatin. Archives of gynecology and obstetrics 299 (4) (2018)

Ilona Bednarek.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ilona Bednarek